-
1دورية أكاديمية
المؤلفون: Bjorkstrand, BB, Ljungman, P, svensson, H, Hermans, J, Alegre, A, Apperley, J, Bladé, J, Carlson, K, Cavo, M, Ferrant, A, Goldstone, AH, de Laurenzi, A, Majolino, I, Marcus, R, Prentice, HG, Remes, K, Samson, D, Sureda, A, Verdonck, LF, Volin, L, Gahrton, G
مصطلحات موضوعية: Acute Disease, Adult, Aged, Blood Transfusion, Autologous, Bone Marrow Transplantation, Case-Control Study, Graft vs Host disease, Hematopoietic Stem Cell Transplantation, multiple Myeloma, Retrospective Studies, Survival Analysis
-
2دورية أكاديمية
المؤلفون: Efficace, Fabio, Gaidano, Gianluca, Petrucci, Maria Teresa, Niscola, Pasquale, Cottone, Francesco, Codeluppi, Katia, Antonioli, Elisabetta, Tafuri, Agostino, Larocca, Alessandra, Potenza, Leonardo, Fozza, Claudio, Pastore, Domenico, Rigolin, Gian Matteo, Offidani, Massimo, Romano, Alessandra, Kyriakou, Charalampia, Cascavilla, Nicola, Gozzetti, Alessandro, Derudas, Daniele, Vignetti, Marco, Cavo, Michele
المساهمون: Efficace, Fabio, Gaidano, Gianluca, Petrucci, Maria Teresa, Niscola, Pasquale, Cottone, Francesco, Codeluppi, Katia, Antonioli, Elisabetta, Tafuri, Agostino, Larocca, Alessandra, Potenza, Leonardo, Fozza, Claudio, Pastore, Domenico, Rigolin, Gian Matteo, Offidani, Massimo, Romano, Alessandra, Kyriakou, Charalampia, Cascavilla, Nicola, Gozzetti, Alessandro, Derudas, Daniele, Vignetti, Marco, Cavo, Michele
مصطلحات موضوعية: adult, aged, Article, cancer recurrence, Charlson Comorbidity Index, clinical assessment tool, cross-sectional study, disease association, dyspnea, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, fatigue, female, frailty, functional assessment, human, insomnia, International Myeloma Working Group frailty score, Italy, Katz Activity of Daily Living, Lawton instrumental activities of daily living scale, major clinical study, male, multicenter study, multiple myeloma, observational study, pain, patient-reported outcome, physician, prevalence, prospective study
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36102777; info:eu-repo/semantics/altIdentifier/wos/WOS:000911713300014; volume:3; issue:9; firstpage:628; lastpage:635; numberofpages:8; journal:THE LANCET. HEALTHY LONGEVITY; https://hdl.handle.net/11392/2496300Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85137293144; https://www.sciencedirect.com/science/article/pii/S2666756822001726Test
الإتاحة: https://doi.org/10.1016/S2666-7568Test(22)00172-6
https://hdl.handle.net/11392/2496300Test
https://www.sciencedirect.com/science/article/pii/S2666756822001726Test -
3دورية أكاديمية
المؤلفون: Parisi S., Ruggeri L., Dan E., Rizzi S., Sinigaglia B., Ocadlikova D., Bontadini A., Giudice V., Urbani E., Ciardelli S., Sartor C., Cristiano G., Nanni J., Zannoni L., Chirumbolo G., Arpinati M., Lewis R. E., Bonifazi F., Marconi G., Martinelli G., Papayannidis C., Paolini S., Velardi A., Cavo M., Lemoli R. M., Curti A.
المساهمون: Parisi, S., Ruggeri, L., Dan, E., Rizzi, S., Sinigaglia, B., Ocadlikova, D., Bontadini, A., Giudice, V., Urbani, E., Ciardelli, S., Sartor, C., Cristiano, G., Nanni, J., Zannoni, L., Chirumbolo, G., Arpinati, M., Lewis, R. E., Bonifazi, F., Marconi, G., Martinelli, G., Papayannidis, C., Paolini, S., Velardi, A., Cavo, M., Lemoli, R. M., Curti, A.
مصطلحات موضوعية: acute myeloid leukemia, adoptive immune therapie, alloreactivity, cell dose, natural killer cell, Aged, Female, Histocompatibility Antigen, Histocompatibility Testing, Human, Immunotherapy, Adoptive, Killer Cells, Natural, Leukemia, Myeloid, Acute, Male, Middle Aged, Prognosi, Treatment Outcome
وصف الملف: ELETTRONICO
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35173709; info:eu-repo/semantics/altIdentifier/wos/WOS:000756939900001; volume:12; firstpage:1; lastpage:6; numberofpages:6; journal:FRONTIERS IN IMMUNOLOGY; http://hdl.handle.net/11567/1078680Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85124594156
-
4دورية أكاديمية
المؤلفون: Visco C., Marcheselli L., Mina R., Sassone M., Guidetti A., Penna D., Cattaneo C., Bonuomo V., Busca A., Ferreri A. J. M., Bruna R., Petrucci L., Cairoli R., Salvini M., Bertu L., Ladetto M., Pilerci S., Pinto A., Ramadan S., Marchesi F., Cavo M., Arcaini L., Coviello E., Romano A., Musto P., Massaia M., Fracchiolla N., Marchetti M., Scattolin A., Tisi M. C., Cuneo A., Porta M. D., Trentin L., Turrini M., Gherlinzoni F., Tafuri A., Galimberti S., Bocchia M., Cardinali V., Cilloni D., Corso A., Armiento D., Rigacci L., La Barbera E. O., Gambacorti-Passerini C., Visani G., Vallisa D., Venditti A., Selleri C., Conconi A., Tosi P., Lanza F., Candoni A., Krampera M., Corradini P., Passamonti F., Merli F.
المساهمون: Visco, C., Marcheselli, L., Mina, R., Sassone, M., Guidetti, A., Penna, D., Cattaneo, C., Bonuomo, V., Busca, A., Ferreri, A. J. M., Bruna, R., Petrucci, L., Cairoli, R., Salvini, M., Bertu, L., Ladetto, M., Pilerci, S., Pinto, A., Ramadan, S., Marchesi, F., Cavo, M., Arcaini, L., Coviello, E., Romano, A., Musto, P., Massaia, M., Fracchiolla, N., Marchetti, M., Scattolin, A., Tisi, M. C., Cuneo, A., Porta, M. D., Trentin, L., Turrini, M., Gherlinzoni, F., Tafuri, A., Galimberti, S., Bocchia, M., Cardinali, V., Cilloni, D., Corso, A., Armiento, D., Rigacci, L., La Barbera, E. O., Gambacorti-Passerini, C., Visani, G., Vallisa, D., Venditti, A., Selleri, C., Conconi, A., Tosi, P., Lanza, F., Candoni, A., Krampera, M., Corradini, P., Passamonti, F., Merli, F.
مصطلحات موضوعية: adolescent, adult, age, aged, Article, cancer diagnosi, cancer patient, cancer survival, child, clinical feature, cohort analysi, controlled study, coronavirus disease 2019, female, follow up, gender, high risk patient, Hodgkin disease, hospitalization, human, Italy, low risk patient, lymphocyte count, lymphoma, major clinical study, male, mortality rate, mortality risk, outpatient, overall survival
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34644385; info:eu-repo/semantics/altIdentifier/wos/WOS:000754251200013; volume:6; issue:1; firstpage:327; lastpage:338; numberofpages:12; journal:BLOOD ADVANCES; https://hdl.handle.net/11392/2472046Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85122929517; https://ashpublications.org/bloodadvances/article/6/1/327/477280/A-prognostic-model-for-patients-with-lymphoma-andTest
الإتاحة: https://doi.org/10.1182/bloodadvances.2021005691Test
https://hdl.handle.net/11392/2472046Test
https://ashpublications.org/bloodadvances/article/6/1/327/477280/A-prognostic-model-for-patients-with-lymphoma-andTest -
5دورية أكاديمية
المؤلفون: Martello M., Poletti A., Borsi E., Solli V., Dozza L., Barbato S., Zamagni E., Tacchetti P., Pantani L., Mancuso K., Vigliotta I., Rizzello I., Rocchi S., Armuzzi S., Testoni N., Marzocchi G., Martinelli G., Cavo M., Terragna C.
المساهمون: Martello M., Poletti A., Borsi E., Solli V., Dozza L., Barbato S., Zamagni E., Tacchetti P., Pantani L., Mancuso K., Vigliotta I., Rizzello I., Rocchi S., Armuzzi S., Testoni N., Marzocchi G., Martinelli G., Cavo M., Terragna C.
مصطلحات موضوعية: Aged, Chromosome Deletion, Disease Progression, Female, Human, Male, Middle Aged, Multiple Myeloma, Mutation, Neoplasm Recurrence, Local, Prognosi, Tumor Suppressor Protein p53, Polymorphism, Single Nucleotide
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35082295; info:eu-repo/semantics/altIdentifier/wos/WOS:000747142500001; volume:12; issue:1; firstpage:15; lastpage:15; numberofpages:1; journal:BLOOD CANCER JOURNAL; http://hdl.handle.net/11585/880016Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123600672; https://doi.org/10.1038/s41408-022-00610-yTest
-
6دورية أكاديمية
المؤلفون: Larocca A., Leleu X., Touzeau C., Blade J., Paner A., Mateos M. -V., Cavo M., Maisel C., Alegre A., Oriol A., Raptis A., Rodriguez-Otero P., Mazumder A., Laubach J., Nadeem O., Sandberg A., Orre M., Torrang A., Bakker N. A., Richardson P. G.
المساهمون: Larocca A., Leleu X., Touzeau C., Blade J., Paner A., Mateos M.-V., Cavo M., Maisel C., Alegre A., Oriol A., Raptis A., Rodriguez-Otero P., Mazumder A., Laubach J., Nadeem O., Sandberg A., Orre M., Torrang A., Bakker N.A., Richardson P.G.
مصطلحات موضوعية: health-related quality of life, melflufen, melphalan flufenamide, patient-reported outcome, relapsed/refractory multiple myeloma, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Biomarkers, Tumor, Dexamethasone, Female, Human, Male, Melphalan, Middle Aged, Multiple Myeloma, Neoplasm Grading, Neoplasm Staging, Patient Reported Outcome Measure, Treatment Outcome
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34671975; info:eu-repo/semantics/altIdentifier/wos/WOS:000709242300001; volume:196; issue:3; firstpage:639; lastpage:648; numberofpages:10; journal:BRITISH JOURNAL OF HAEMATOLOGY; http://hdl.handle.net/2318/1846953Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85117392564; https://doi.org/10.1111/bjh.17887Test
-
7دورية أكاديمية
المؤلفون: Larocca, Alessandra, Leleu, Xavier, Touzeau, Cyrille, Bladé Creixenti, Juan, Paner, Agne, Mateos, M. V, Cavo, Michele, Maisel, Christopher, Alegre, Adrian, Oriol, Albert, Raptis, Anastasios, Rodriguez-Otero, Paula, Mazumder, Amitabha, Laubach, Jacob, Nadeem, Omar, Sandberg, Anna, Orre, Marie, TorrÃ¥ng, Anna, Bakker, Nicolaas A, Richardson, Paul G., Universitat Autònoma de Barcelona
مصطلحات موضوعية: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Dexamethasone, Female, Humans, Male, Melphalan, Middle Aged, Multiple Myeloma, Neoplasm Grading, Neoplasm Staging, Patient Reported Outcome Measures, Treatment Outcome
وصف الملف: application/pdf
العلاقة: British Journal of Haematology; Vol. 196 Núm. 3 (february 2022), p. 639-648; https://ddd.uab.cat/record/270639Test; urn:10.1111/bjh.17887; urn:oai:ddd.uab.cat:270639; urn:scopus_id:85117392564; urn:articleid:13652141v196n3p639; urn:pmid:34671975; urn:pmc-uid:9135124; urn:pmcid:PMC9135124; urn:oai:pubmedcentral.nih.gov:9135124
-
8دورية أكاديمية
المؤلفون: Passamonti F., Romano A., Salvini M., Merli F., Porta M. G. D., Bruna R., Coviello E., Romano I., Cairoli R., Lemoli R., Farina F., Venditti A., Busca A., Ladetto M., Massaia M., Pinto A., Arcaini L., Tafuri A., Marchesi F., Fracchiolla N., Bocchia M., Armiento D., Candoni A., Krampera M., Luppi M., Cardinali V., Galimberti S., Cattaneo C., La Barbera E. O., Mina R., Lanza F., Visani G., Musto P., Petrucci L., Zaja F., Grossi P. A., Bertu L., Pagano L., Corradini P., Derenzini E., Marchetti M., Scattolin A. M., Corso A., Tosi P., Gherlinzoni F., Passerini C. G., Cavo M., Fava C., Turrini M., Visco C., Zappasodi P., Merli M., Mora B., Vannucchi A. M.
المساهمون: Passamonti, F., Romano, A., Salvini, M., Merli, F., Porta, M. G. D., Bruna, R., Coviello, E., Romano, I., Cairoli, R., Lemoli, R., Farina, F., Venditti, A., Busca, A., Ladetto, M., Massaia, M., Pinto, A., Arcaini, L., Tafuri, A., Marchesi, F., Fracchiolla, N., Bocchia, M., Armiento, D., Candoni, A., Krampera, M., Luppi, M., Cardinali, V., Galimberti, S., Cattaneo, C., La Barbera, E. O., Mina, R., Lanza, F., Visani, G., Musto, P., Petrucci, L., Zaja, F., Grossi, P. A., Bertu, L., Pagano, L., Corradini, P., Derenzini, E., Marchetti, M., Scattolin, A. M., Corso, A., Tosi, P., Gherlinzoni, F., Passerini, C. G., Cavo, M., Fava, C., Turrini, M., Visco, C., Zappasodi, P., Merli, M., Mora, B., Vannucchi, A. M.
مصطلحات موضوعية: Covid-19, leukemia, lymphoma, myeloma, SARS-CoV-2, Adult, Aged, 80 and over, Antibodies, Viral, Female, Hematologic Neoplasm, Human, Immunoglobulin G, Male, Middle Aged, Seroconversion, Young Adult, Antibody Formation
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34272724; info:eu-repo/semantics/altIdentifier/wos/WOS:000673218400001; volume:195; issue:3; firstpage:371; lastpage:377; journal:BRITISH JOURNAL OF HAEMATOLOGY; http://hdl.handle.net/11380/1280502Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85110661399
-
9دورية أكاديمية
المؤلفون: Auner H. W., Gavriatopoulou M., Delimpasi S., Simonova M., Spicka I., Pour L., Dimopoulos M. A., Kriachok I., Pylypenko H., Leleu X., Doronin V., Usenko G., Hajek R., Benjamin R., Dolai T. K., Sinha D. K., Venner C. P., Garg M., Stevens D. A., Quach H., Jagannath S., Moreau P., Levy M., Badros A., Anderson L. D., Bahlis N. J., Facon T., Mateos M. V., Cavo M., Chai Y., Arazy M., Shah J., Shacham S., Kauffman M. G., Richardson P. G., Grosicki S.
المساهمون: Auner H.W., Gavriatopoulou M., Delimpasi S., Simonova M., Spicka I., Pour L., Dimopoulos M.A., Kriachok I., Pylypenko H., Leleu X., Doronin V., Usenko G., Hajek R., Benjamin R., Dolai T.K., Sinha D.K., Venner C.P., Garg M., Stevens D.A., Quach H., Jagannath S., Moreau P., Levy M., Badros A., Anderson L.D., Bahlis N.J., Facon T., Mateos M.V., Cavo M., Chai Y., Arazy M., Shah J., Shacham S., Kauffman M.G., Richardson P.G., Grosicki S.
مصطلحات موضوعية: Adult, Age Factor, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Clinical Trials, Phase III as Topic, Dexamethasone, Drug Administration Schedule, Female, Frailty, Gastrointestinal Disease, Hematologic Disease, Human, Hydrazine, Kaplan-Meier Estimate, Male, Middle Aged, Multicenter Studies as Topic, Multiple Myeloma, Peripheral Nervous System Disease, Progression-Free Survival, Randomized Controlled Trials as Topic, Retrospective Studie, Severity of Illness Index, Triazoles
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33755235; info:eu-repo/semantics/altIdentifier/wos/WOS:000646325700001; volume:96; issue:6; firstpage:708; lastpage:718; numberofpages:11; journal:AMERICAN JOURNAL OF HEMATOLOGY; https://hdl.handle.net/11585/865006Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104358050
-
10دورية أكاديمية
المؤلفون: Richardson P. G., Oriol A., Larocca A., Blade J., Cavo M., Rodriguez-Otero P., Leleu X., Nadeem O., Hiemenz J. W., Hassoun H., Touzeau C., Alegre A., Paner A., Maisel C., Mazumder A., Raptis A., Moreb J. S., Anderson K. C., Laubach J. P., Thuresson S., Thuresson M., Byrne C., Harmenberg J., Bakker N. A., Mateos M. -V.
المساهمون: Richardson P.G., Oriol A., Larocca A., Blade J., Cavo M., Rodriguez-Otero P., Leleu X., Nadeem O., Hiemenz J.W., Hassoun H., Touzeau C., Alegre A., Paner A., Maisel C., Mazumder A., Raptis A., Moreb J.S., Anderson K.C., Laubach J.P., Thuresson S., Thuresson M., Byrne C., Harmenberg J., Bakker N.A., Mateos M.-V.
مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Dexamethasone, Disease Progression, Drug Resistance, Neoplasm, Europe, Female, Human, Male, Melphalan, Middle Aged, Multiple Myeloma, Phenylalanine, Progression-Free Survival, Recurrence, Time Factor, United States
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33296242; info:eu-repo/semantics/altIdentifier/wos/WOS:000635371200008; volume:39; issue:7; firstpage:757; lastpage:767; numberofpages:11; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11585/865203Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85101703700
